Acute and chronic neutral endopeptidase inhibition in rats with aortocaval shunt.
暂无分享,去创建一个
[1] D. Ganten,et al. Effects of human renin in the vasculature of rats transgenic for human angiotensinogen. , 1995, Hypertension.
[2] J. Stasch,et al. Prolonged inhibition of neutral endopeptidase 24.11 by sinorphan in stroke-prone spontaneously hypertensive rats. , 1995, Hypertension research : official journal of the Japanese Society of Hypertension.
[3] F. Pieruzzi,et al. Pulmonary and renal neutral endopeptidase EC 3.4.24.11 in rats with experimental heart failure. , 1995, Hypertension.
[4] T. Ogihara,et al. Antihypertensive effects of the neutral endopeptidase inhibitor SCH 42495 in essential hypertension. , 1994, American journal of hypertension.
[5] T. Ogihara,et al. Autocrine and paracrine effects of atrial natriuretic peptide gene transfer on vascular smooth muscle and endothelial cellular growth. , 1994, The Journal of clinical investigation.
[6] R. Dietz,et al. [Induction of the atrial and ventricular ANF synthesis in experimental heart failure after aortocaval shunt]. , 1993, Zeitschrift fur Kardiologie.
[7] J. Scott,et al. Renal effects of neutral endopeptidase inhibition in euvolemic and hypervolemic rats. , 1993, European journal of pharmacology.
[8] M. Wilkins,et al. Effect of endopeptidase‐24.11 inhibition and of atrial natriuretic peptide clearance receptor ligand on the response to rat brain natriuretic peptide in the conscious rat , 1993, British journal of pharmacology.
[9] H. Cheung,et al. Inhibition of neutral endopeptidase 3.4.24.11 in conscious dogs with pacing induced heart failure. , 1993, Cardiovascular research.
[10] B. Neustadt,et al. Atrial natriuretic factor potentiating and hemodynamic effects of SCH 42495, a new, neutral metalloendopeptidase inhibitor. , 1993, American journal of hypertension.
[11] G. Wittert,et al. Chronic inhibition of endopeptidase 24.11 in essential hypertension: evidence for enhanced atrial natriuretic peptide and angiotensin II , 1993, Journal of hypertension.
[12] A. Kenny,et al. Hydrolysis of human and pig brain natriuretic peptides, urodilatin, C-type natriuretic peptide and some C-receptor ligands by endopeptidase-24.11. , 1993, The Biochemical journal.
[13] R. Ardaillou,et al. Characterization of neutral endopeptidase in vascular smooth muscle cells of rabbit renal cortex. , 1993, The American journal of physiology.
[14] I. Ichikawa,et al. Biological significance of atrial natriuretic peptide in the kidney. , 1993, Nephron.
[15] S. Hunsberger,et al. Pharmacokinetics of ANF and urodilatin during cANF receptor blockade and neutral endopeptidase inhibition. , 1992, The American journal of physiology.
[16] D. Goeddel,et al. Molecular Biology of the Natriuretic Peptides and Their Receptors , 1992, Circulation.
[17] E. Ongini,et al. The Neutral Endopeptidase Inhibitor, SCH 34826, Reduces Left Ventricular Hypertrophy in Spontaneously Hypertensive Rats , 1992, Journal of cardiovascular pharmacology.
[18] G. Riegger,et al. Effectiveness of endopeptidase inhibition (candoxatril) in congestive heart failure. , 1992, The American journal of cardiology.
[19] C. Frampton,et al. Acute Inhibition of Endopeptidase 24.11 in Essential Hypertension: SCH 34826 Enhances Atrial Natriuretic Peptide and Natriuresis Without Lowering Blood Pressure , 1992, Journal of cardiovascular pharmacology.
[20] D. de Zeeuw,et al. Atrial natriuretic factor: its (patho)physiological significance in humans. , 1992, Kidney international.
[21] N. Markandu,et al. Is atrial natriuretic peptide-guanosine 3',5' cyclic monophosphate coupling a determinant of urinary sodium excretion in essential hypertension? , 1992, Journal of hypertension.
[22] E. Ongini,et al. Chronic inhibition of neutral endopeptidase reduces left ventricular hypertrophy without changing blood pressure in spontaneously hypertensive rats. , 1991, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.
[23] N. Markandu,et al. Dietary Sodium and Inhibition of Neutral Endopeptidase 24.11 in Essential Hypertension , 1991, Hypertension.
[24] K. Margulies,et al. Angiotensin inhibition potentiates the renal responses to neutral endopeptidase inhibition in dogs with congestive heart failure. , 1991, The Journal of clinical investigation.
[25] G. Wittert,et al. Prolonged inhibition of endopeptidase 24.11 in normal man: renal, endocrine and haemodynamic effects. , 1991, Journal of hypertension.
[26] N. Trippodo,et al. Heart Failure Augments the Cardiovascular and Renal Effects of Neutral Endopeptidase Inhibition in Rats , 1991, Journal of cardiovascular pharmacology.
[27] M. Burnier,et al. Effects of SCH 34826, an orally active inhibitor of atrial natriuretic peptide degradation, in healthy volunteers , 1991, Clinical pharmacology and therapeutics.
[28] R. Re,et al. Growth factors and cardiovascular structure. Implications for calcium antagonist therapy. , 1991, American journal of hypertension.
[29] I. Tikkanen,et al. Prolonged neutral endopeptidase inhibition in heart failure. , 1991, European journal of pharmacology.
[30] N. Salès,et al. Neutral endopeptidase 24.11 in rat peripheral tissues: comparative localization by ‘ex vivo’ and ‘in vitro’ autoradiography , 1991, Regulatory Peptides.
[31] K. Margulies,et al. ANF-mediated renal cGMP generation in congestive heart failure. , 1991, The American journal of physiology.
[32] R. Dietz,et al. Transcription, storage and release of atrial natriuretic factor in the failing human heart. , 1991, Clinical science.
[33] J. Hunt,et al. Possible regulation of atrial natriuretic factor by neutral endopeptidase 24.11 and clearance receptors. , 1991, The Journal of pharmacology and experimental therapeutics.
[34] B. Berk,et al. Long-term regulation of Na(+)-H+ exchange in vascular smooth muscle cells: role of protein kinase C. , 1991, The American journal of physiology.
[35] M. Bolgar,et al. Degradation of brain natriuretic peptide by neutral endopeptidase: species specific sites of proteolysis determined by mass spectrometry. , 1991, Biochemical and biophysical research communications.
[36] C. Foster,et al. Influence of C-ANF receptor and neutral endopeptidase on pharmacokinetics of ANF in rats. , 1991, The American journal of physiology.
[37] P. Needleman,et al. Maximizing the natriuretic effect of endogenous atriopeptin in a rat model of heart failure. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[38] K. Margulies,et al. Cardiorenal actions of neutral endopeptidase inhibition in experimental congestive heart failure. , 1990, Circulation.
[39] R. Garcia,et al. Simple, rapid, and effective method of producing aortocaval shunts in the rat. , 1990, Cardiovascular research.
[40] P. Chiu,et al. Atrial Natriuretic Factor‐Potentiating and Antihypertensive Activity of SCH 34826: An Orally Active Neutral Metalloendopeptidase Inhibitor , 1990, Hypertension.
[41] E. Chen,et al. Differential activation by atrial and brain natriuretic peptides of two different receptor guanylate cyclases , 1989, Nature.
[42] E. H. Blaine,et al. Thiorphan, an Inhibitor of Endopeptidase 24.11, Potentiates the Natriuretic Activity of Atrial Natriuretic Peptide , 1989, Journal of cardiovascular pharmacology.
[43] C. McMartin,et al. Degradation of Atrial Natriuretic Peptide: Pharmacologic Effects of Protease EC 24.11 Inhibition , 1989, Journal of cardiovascular pharmacology.
[44] W. Forssmann,et al. Degradation of porcine brain natriuretic peptide (pBNP-26) by endoprotease-24.11 from kidney cortical membranes. , 1989, Biochemical and biophysical research communications.
[45] D. Goeddel,et al. A membrane form of guanylate cyclase is an atrial natriuretic peptide receptor , 1989, Nature.
[46] T. Inagami,et al. Atrial natriuretic factor. , 1989, The Journal of biological chemistry.
[47] R. Skidgel,et al. Neutral endopeptidase 24.11 (enkephalinase) and related regulators of peptide hormones 1 , 1989, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[48] R. Rodeheffer,et al. Clearance of atrial natriuretic factor by lung, liver, and kidney in human subjects and the dog. , 1989, The Journal of clinical investigation.
[49] K. Hosoda,et al. Augmented expression of atrial natriuretic polypeptide gene in ventricle of human failing heart. , 1989, The Journal of clinical investigation.
[50] L. Wennogle,et al. Identification of protease 3.4.24.11 as the major atrial natriuretic factor degrading enzyme in the rat kidney , 1988, Peptides.
[51] M. Imai,et al. Intrarenal localization of degradation of atrial natriuretic peptide in isolated glomeruli and cortical nephron segments. , 1988, Life sciences.
[52] J. Lewicki,et al. Physiological role of silent receptors of atrial natriuretic factor. , 1987, Science.
[53] H. Zurcher-Neely,et al. Inactivation of atrial natriuretic factor by the renal brush border. , 1987, Biochimica et biophysica acta.
[54] K. Jakobs,et al. Neuropeptide Y inhibits renin release by a pertussis toxin-sensitive mechanism. , 1987, The American journal of physiology.
[55] J. Michel,et al. Myocardial recruitment during ANF mRNA increase with volume overload in the rat. , 1986, The American journal of physiology.
[56] M. Cantin,et al. Atrial natriuretic factor in human plasma. , 1986, Biochemical and biophysical research communications.
[57] D. Ganten,et al. Atriopeptin III kinetics and pharmacodynamics in normal and anephric rats. , 1986, The Journal of pharmacology and experimental therapeutics.
[58] N. Gee,et al. An immunoradiometric assay for endopeptidase-24.11 shows it to be a widely distributed enzyme in pig tissues. , 1985, The Biochemical journal.
[59] F. Murad,et al. Atrial natriuretic factor selectively activates particulate guanylate cyclase and elevates cyclic GMP in rat tissues. , 1984, The Journal of biological chemistry.
[60] M. Cantin,et al. Effect of native and synthetic atrial natriuretic factor on cyclic GMP. , 1984, Biochemical and biophysical research communications.
[61] P. Hamet,et al. Preparation of cyclic nucleotide antisera with thyroglobulin-cyclic nucleotide conjugates. , 1980, Journal of cyclic nucleotide research.